$2.51 Billion is the total value of Cormorant Asset Management, LP's 67 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 42.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TPTX | Sell | TURNING POINT THERAPEUTICS I | $211,577,000 | +58.9% | 3,396,650 | -4.1% | 8.44% | +4.2% |
| RETA | Sell | REATA PHARMACEUTICALS INCcl a | $166,897,000 | +153.6% | 816,400 | -0.4% | 6.66% | +66.2% |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $165,249,000 | +32.6% | 1,282,392 | -19.9% | 6.59% | -13.1% |
| CCXI | Buy | CHEMOCENTRYX INC | $114,695,000 | +829.5% | 2,900,000 | +59.3% | 4.58% | +509.5% |
| PRNB | Buy | PRINCIPIA BIOPHARMA INC | $109,063,000 | +187.8% | 1,990,922 | +48.4% | 4.35% | +88.6% |
| CNST | Buy | CONSTELLATION PHARMCETICLS I | $108,353,000 | +1282.4% | 2,300,000 | +89.6% | 4.32% | +806.5% |
| BBIO | Sell | BRIDGEBIO PHARMA INC | $88,076,000 | +56.7% | 2,512,865 | -4.0% | 3.52% | +2.7% |
| APLS | Sell | APELLIS PHARMACEUTICALS INC | $82,674,000 | +15.3% | 2,700,000 | -9.3% | 3.30% | -24.4% |
| MRTX | Buy | MIRATI THERAPEUTICS INCcall | $64,430,000 | +313.5% | 500,000 | +150.0% | 2.57% | +170.9% |
| AXSM | New | AXSOME THERAPEUTICS INC | $62,016,000 | – | 600,000 | +100.0% | 2.48% | – |
| CRSP | Sell | CRISPR THERAPEUTICS AGnamen akt | $60,905,000 | +37.0% | 1,000,000 | -7.8% | 2.43% | -10.2% |
| NXTC | Buy | NEXTCURE INC | $56,330,000 | +106.4% | 1,000,000 | +13.0% | 2.25% | +35.3% |
| ASND | Sell | ASCENDIS PHARMA A Ssponsored adr | $55,648,000 | +23.4% | 400,000 | -14.6% | 2.22% | -19.1% |
| BHVN | Sell | BIOHAVEN PHARMACTL HLDG CO L | $54,440,000 | +1.8% | 1,000,000 | -22.0% | 2.17% | -33.3% |
| RETA | New | REATA PHARMACEUTICALS INCcall | $51,108,000 | – | 250,000 | +100.0% | 2.04% | – |
| MYOK | Buy | MYOKARDIA INC | $51,020,000 | +120.8% | 700,000 | +58.0% | 2.04% | +44.8% |
| STOK | Buy | STOKE THERAPEUTICS INC | $50,654,000 | +31.8% | 1,788,643 | +0.0% | 2.02% | -13.6% |
| YMAB | Buy | Y-MABS THERAPEUTICS INC | $50,074,000 | +117.4% | 1,602,376 | +81.3% | 2.00% | +42.5% |
| XBI | Buy | SPDR SERIES TRUSTput | $47,555,000 | +55.9% | 500,000 | +25.0% | 1.90% | +2.2% |
| RCKT | Sell | ROCKET PHARMACEUTICALS INC | $41,816,000 | +69.0% | 1,837,269 | -13.5% | 1.67% | +10.8% |
| VIE | New | VIELA BIO INC | $40,657,000 | – | 1,497,500 | +100.0% | 1.62% | – |
| TCDA | Sell | TRICIDA INC | $35,022,000 | +4.8% | 927,975 | -14.3% | 1.40% | -31.3% |
| ASND | ASCENDIS PHARMA A Scall | $34,780,000 | +44.4% | 250,000 | 0.0% | 1.39% | -5.3% | |
| AXNX | AXONICS MODULATION TECH INC | $33,880,000 | +2.9% | 1,222,671 | 0.0% | 1.35% | -32.5% | |
| QTNT | Sell | QUOTIENT LTD | $33,285,000 | +17.6% | 3,500,000 | -3.9% | 1.33% | -22.9% |
| SRPT | Buy | SAREPTA THERAPEUTICS INC | $32,260,000 | +93.2% | 250,000 | +12.8% | 1.29% | +26.7% |
| ZYME | New | ZYMEWORKS INC | $31,822,000 | – | 700,000 | +100.0% | 1.27% | – |
| MYOV | New | MYOVANT SCIENCES LTD | $31,040,000 | – | 2,000,000 | +100.0% | 1.24% | – |
| CABA | New | CABALETTA BIO INC | $29,604,000 | – | 2,119,132 | +100.0% | 1.18% | – |
| QURE | Sell | UNIQURE NV | $28,664,000 | -19.1% | 400,000 | -55.6% | 1.14% | -46.9% |
| ALLK | Sell | ALLAKOS INC | $28,608,000 | -18.1% | 300,000 | -32.4% | 1.14% | -46.3% |
| EIDX | Sell | EIDOS THERAPEUTICS INC | $28,448,000 | +46.3% | 495,692 | -8.3% | 1.14% | -4.1% |
| DCPH | Sell | DECIPHERA PHARMACEUTICALS IN | $28,008,000 | +4.7% | 450,000 | -42.9% | 1.12% | -31.4% |
| AMRN | Sell | AMARIN CORP PLCspons adr new | $27,872,000 | +38.0% | 1,300,000 | -2.4% | 1.11% | -9.5% |
| BPMC | Sell | BLUEPRINT MEDICINES CORP | $27,638,000 | -23.7% | 345,000 | -30.0% | 1.10% | -50.0% |
| BHVN | Sell | BIOHAVEN PHARMACTL HLDG CO Lcall | $27,220,000 | +8.7% | 500,000 | -16.7% | 1.09% | -28.7% |
| IMVTU | New | IMMUNOVANT INCunit 12/18/2024 | $26,548,000 | – | 1,080,000 | +100.0% | 1.06% | – |
| OMER | New | OMEROS CORP | $21,487,000 | – | 1,525,000 | +100.0% | 0.86% | – |
| GLPG | Sell | GALAPAGOS NVspon adr | $20,921,000 | -8.5% | 100,000 | -33.3% | 0.84% | -40.0% |
| STSA | SATSUMA PHARMACEUTICALS INC | $16,893,000 | +31.1% | 858,382 | 0.0% | 0.67% | -14.0% | |
| AKRO | AKERO THERAPEUTICS INC | $16,438,000 | -2.4% | 740,621 | 0.0% | 0.66% | -36.1% | |
| ARGX | Sell | ARGENX SEsponsored adr | $16,052,000 | +10.0% | 100,000 | -21.9% | 0.64% | -27.9% |
| TWST | TWIST BIOSCIENCE CORP | $14,430,000 | -12.1% | 687,149 | 0.0% | 0.58% | -42.3% | |
| MRUS | New | MERUS N V | $14,080,000 | – | 1,000,000 | +100.0% | 0.56% | – |
| RARX | RA PHARMACEUTICALS INC | $13,873,000 | +98.4% | 295,600 | 0.0% | 0.55% | +30.0% | |
| KURA | Sell | KURA ONCOLOGY INC | $13,750,000 | -26.4% | 1,000,000 | -18.8% | 0.55% | -51.7% |
| SRNE | New | SORRENTO THERAPEUTICS INC | $13,520,000 | – | 4,000,000 | +100.0% | 0.54% | – |
| INSP | INSPIRE MED SYS INC | $12,786,000 | +21.6% | 172,300 | 0.0% | 0.51% | -20.3% | |
| EIGR | Sell | EIGER BIOPHARMACEUTICALS INC | $12,418,000 | +21.4% | 833,400 | -16.5% | 0.50% | -20.4% |
| ZLAB | ZAI LAB LTDadr | $11,527,000 | +28.6% | 277,161 | 0.0% | 0.46% | -15.8% | |
| CCXI | New | CHEMOCENTRYX INCcall | $9,888,000 | – | 250,000 | +100.0% | 0.40% | – |
| HARP | HARPOON THERAPEUTICS INC | $9,613,000 | +8.3% | 649,994 | 0.0% | 0.38% | -28.9% | |
| ARNA | ARENA PHARMACEUTICALS INC | $7,826,000 | -0.8% | 172,300 | 0.0% | 0.31% | -35.0% | |
| DTIL | Sell | PRECISION BIOSCIENCES INC | $6,494,000 | +65.6% | 467,516 | -0.0% | 0.26% | +8.4% |
| AVRO | Sell | AVROBIO INC | $6,393,000 | -20.3% | 317,579 | -44.1% | 0.26% | -47.7% |
| AUTL | AUTOLUS THERAPEUTICS PLCspon ads | $6,336,000 | +6.3% | 479,988 | 0.0% | 0.25% | -30.3% | |
| IGMS | IGM BIOSCIENCES INC | $5,968,000 | +115.0% | 156,400 | 0.0% | 0.24% | +40.8% | |
| ANAB | Sell | ANAPTYSBIO INC | $5,931,000 | -71.3% | 365,000 | -38.3% | 0.24% | -81.2% |
| BCEL | Sell | ATRECA INC | $5,045,000 | +1.5% | 326,141 | -19.7% | 0.20% | -33.7% |
| ORTX | Sell | ORCHARD THERAPEUTICS PLCads | $4,815,000 | -40.0% | 350,203 | -48.1% | 0.19% | -60.7% |
| GOSS | Sell | GOSSAMER BIO INC | $4,689,000 | -54.8% | 300,000 | -51.5% | 0.19% | -70.4% |
| NERV | MINERVA NEUROSCIENCES INC | $4,322,000 | -8.3% | 607,903 | 0.0% | 0.17% | -40.1% | |
| NKTR | Sell | NEKTAR THERAPEUTICS | $4,317,000 | -70.0% | 200,000 | -74.6% | 0.17% | -80.3% |
| NBIX | NEUROCRINE BIOSCIENCES INC | $4,224,000 | +19.3% | 39,300 | 0.0% | 0.17% | -21.8% | |
| XFOR | Sell | X4 PHARMACEUTICALS INC | $2,704,000 | -75.9% | 252,747 | -71.3% | 0.11% | -84.2% |
| TBPH | New | THERAVANCE BIOPHARMA INC | $1,295,000 | – | 50,000 | +100.0% | 0.05% | – |
| OTLKW | OUTLOOK THERAPEUTICS INC*w exp 02/18/202 | $27,000 | -46.0% | 416,666 | 0.0% | 0.00% | -66.7% | |
| OTLK | Exit | OUTLOOK THERAPEUTICS INC | $0 | – | -15,753 | -100.0% | -0.00% | – |
| ACRS | Exit | ACLARIS THERAPEUTICS INC | $0 | – | -250,000 | -100.0% | -0.02% | – |
| ABEO | Exit | ABEONA THERAPEUTICS INC | $0 | – | -200,000 | -100.0% | -0.03% | – |
| IFRX | Exit | INFLARX NV | $0 | – | -300,000 | -100.0% | -0.04% | – |
| XLRN | Exit | ACCELERON PHARMA INC | $0 | – | -25,000 | -100.0% | -0.06% | – |
| GTHX | Exit | G1 THERAPEUTICS INC | $0 | – | -1,000 | -100.0% | -0.06% | – |
| SRRK | Exit | SCHOLAR ROCK HLDG CORP | $0 | – | -118,950 | -100.0% | -0.06% | – |
| BOLD | Exit | AUDENTES THERAPEUTICS INC | $0 | – | -50,000 | -100.0% | -0.09% | – |
| ADVM | Exit | ADVERUM BIOTECHNOLOGIES INCcall | $0 | – | -300,000 | -100.0% | -0.10% | – |
| ITRM | Exit | ITERUM THERAPEUTICS PLC | $0 | – | -396,385 | -100.0% | -0.14% | – |
| KZR | Exit | KEZAR LIFE SCIENCES INC | $0 | – | -927,869 | -100.0% | -0.18% | – |
| PHAS | Exit | PHASEBIO PHARMACEUTICALS INC | $0 | – | -816,448 | -100.0% | -0.21% | – |
| RUBY | Exit | RUBIUS THERAPEUTICS INC | $0 | – | -491,700 | -100.0% | -0.24% | – |
| ATRA | Exit | ATARA BIOTHERAPEUTICS INC | $0 | – | -300,000 | -100.0% | -0.26% | – |
| FIXX | Exit | HOMOLOGY MEDICINES INC | $0 | – | -245,100 | -100.0% | -0.27% | – |
| GNFT | Exit | GENFIT S Aads | $0 | – | -300,000 | -100.0% | -0.32% | – |
| HSACU | Exit | HEALTH SCIENCES ACQUISITN CORPunit 04/01/2024 | $0 | – | -1,080,000 | -100.0% | -0.70% | – |
| SAGE | Exit | SAGE THERAPEUTICS INC | $0 | – | -88,700 | -100.0% | -0.76% | – |
| MRTX | Exit | MIRATI THERAPEUTICS INCput | $0 | – | -550,000 | -100.0% | -2.61% | – |
| SPY | Exit | SPDR S&P 500 ETF TRput | $0 | – | -400,000 | -100.0% | -7.23% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| QUOTIENT LTD | 30 | Q3 2021 | 4.3% |
| ASCENDIS PHARMA A/S | 30 | Q4 2022 | 4.8% |
| MINERVA NEUROSCIENCES INC | 29 | Q3 2021 | 4.4% |
| ACCELERON PHARMA INC | 28 | Q2 2021 | 3.4% |
| OMEROS CORP | 27 | Q3 2021 | 6.5% |
| MIRATI THERAPEUTICS INC | 25 | Q4 2022 | 7.6% |
| BLUEPRINT MEDICINES CORP | 25 | Q3 2021 | 3.6% |
| APELLIS PHARMACEUTICALS INC | 24 | Q3 2023 | 8.6% |
| NEUROCRINE BIOSCIENCES INC | 24 | Q1 2020 | 4.6% |
| ROCKET PHARMACEUTICALS, INC | 23 | Q3 2023 | 2.4% |
View Cormorant Asset Management, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Ambrx Biopharma Inc. | March 13, 2023 | 42,771,365 | - |
| Altimmune, Inc. | February 14, 2023 | 2,600,000 | - |
| Arcellx, Inc. | February 14, 2023 | 2,075,000 | - |
| BioAtla, Inc. | February 14, 2023 | 2,499,250 | - |
| Eledon Pharmaceuticals, Inc. | February 14, 2023 | 1,391,663 | - |
| GreenLight Biosciences Holdings, PBC | February 14, 2023 | 4,751,020 | - |
| Prometheus Biosciences, Inc. | February 14, 2023 | 700,000 | - |
| Tango Therapeutics, Inc. | February 14, 2023 | 1,000,000 | - |
| VectivBio Holding AG | February 14, 2023 | 1,515,087 | - |
| Viridian Therapeutics, Inc.\DE | February 14, 2023 | 1,100,000 | - |
View Cormorant Asset Management, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-04-29 |
| 4 | 2024-04-22 |
| SC 13G/A | 2024-04-15 |
| 4 | 2024-04-03 |
| SC 13G | 2024-03-21 |
| 4 | 2024-03-18 |
| SC 13G/A | 2024-03-18 |
| 4 | 2024-03-11 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Cormorant Asset Management, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.